Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Prescription costs review due in autumn

  • Comment

The health minister has said a delayed review into the cost of prescriptions will be published in the autumn.

It is expected that the review headed by Professor Ian Gilmore, president of the Royal College of Physicians, will include a revised list of conditions exempt from payment following on from charges for cancer patients which were abolished in England in April.

At a cost of more than £150,000 the review has covered ‘deliberative research, stakeholder workshops and meetings’, but ‘further work to ensure that proposals can be implemented smoothly and efficiently’ has delayed its publication from the original summer due date.

Despite the existing costs minister Mike O’Brien said more spending was likely as Professor Gilmore completed the review.

The Government has faced criticism for increasing the price of prescriptions up to £7.20 in April despite calls from the British Medical Association to follow examples set in Northern Ireland, Scotland and Wales and abolish charges altogether.

Prescriptions in Wales are already free and Northern Ireland will be abolishing the charges next year. Scotland will follow suit from 2011.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs